Amanda M. Smith

Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT+ Cancers

Kathryn G. Roberts, Amanda M. Smith, Fiona McDougall et al. · Cancer Research · 2010 · 130 citations · Full text

Medicine, Oncology, Pharmacology +17

A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra

HeatherA . Boger, L.D. Middaugh, Peng Huang et al. · Experimental Neurology · 2006 · 111 citations

Life Sciences, Neurology, Neuroscience +17

Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies

Christopher B. Cole, David A. Russler‐Germain, Shamika Ketkar et al. · Journal of Clinical Investigation · 2017 · 89 citations · Full text

Medicine, Genetics, Molecular Biology +16

Silver Impairs Neurodevelopment: Studies in PC12 Cells

Christina M. Powers, Nicola Wrench, Ian T. Ryde et al. · Environmental Health Perspectives · 2009 · 69 citations · Full text

Pharmacy, Neurobiology, Neuroscience +17

Mutations in ALDH6A1 encoding methylmalonate semialdehyde dehydrogenase are associated with dysmyelination and transient methylmalonic aciduria

Julien Marcadier, Amanda M. Smith, Daniela Pohl et al. · Orphanet Journal of Rare Diseases · 2013 · 53 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17